New Four-in-One antibody takes on Hard-to-Treat blood cancers
NCT ID NCT05104775
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 24 times
Summary
This early-phase study tests a new drug called GNC-035 in 33 adults with blood cancers that have come back or not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. The drug is a special antibody designed to attack cancer cells in multiple ways.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, China
-
Guangzhou First People's Hospital
Guangzhou, Guangdong, China
-
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
-
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
-
The Second People's Hospital of Yibin
Yibin, Sichuang, China
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
Conditions
Explore the condition pages connected to this study.